1. Home
  2. SNOA

SNOA

Sonoma Pharmaceuticals Inc.

Logo Sonoma Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-23-2024 12:58pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.

Founded: N/A Country:
United States
United States
Employees: N/A City: BOULDER
Market Cap: 2.7M IPO Year: 2007
Target Price: $3.25 AVG Volume (30 days): 1.5M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.94 EPS Growth: N/A
52 Week Low/High: $0.12 - $1.52 Next Earning Date: 02-08-2024
Revenue: $12,310,000 Revenue Growth: -1.96%
Revenue Growth (this year): 12.59% Revenue Growth (next year): 22.25%

Share on Social Networks: